New Breast Cancer Research Trial at NYOH
NYOH is currently enrolling eligible breast cancer patients in a new clinical research trial for Embraca. This Phase III research study is for those with advanced of metastatic breast cancer who also have the inherited BRCA 1 or 2 mutation.
For more information, please call NYOH 518-489-3612 x1045.
Visit www.newyorkoncology.com/clinical-trials-research/ for a full list of open trials, available at NYOH locations.